Brentuximab Vedotin and its Impurities
Brentuximab vedotin, sold under the brand name Adcetris, is an antibody-drug conjugate medication used to treat relapsed or refractory Hodgkin lymphoma. Reference standards of Brentuximab Vedotin API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.